Search filters

List of works by Michele T. Yip-Schneider

A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer

scientific article published on 01 April 2019

A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm Dysplasia

scientific article published on 04 August 2020

A combination of molecular markers and clinical features improve the classification of pancreatic cysts

scientific article

A multimodality test to guide the management of patients with a pancreatic cyst

scientific article published on 01 July 2019

Alcohol activates the hedgehog pathway and induces related procarcinogenic processes in the alcohol-preferring rat model of hepatocarcinogenesis.

scientific article

Alcohol induces liver neoplasia in a novel alcohol-preferring rat model

scientific article

Circulating Leptin and Branched Chain Amino Acids-Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade

scientific article published on 13 September 2018

Circulating Thrombospondin-2 enhances prediction of malignant intraductal papillary mucinous neoplasm

scientific article published on 07 September 2018

Clinical criteria for integrated molecular pathology in intraductal papillary mucinous neoplasm: less is more

scientific article published on 05 October 2018

Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

scientific article published on 5 September 2017

Cyclo-oxygenase-2 expression in primary cancers of the lung and bladder compared to normal adjacent tissue

scientific article published on 01 January 2002

Cyclooxygenase-2 expression in hamster and human pancreatic neoplasia

scientific article

DNA profile components predict malignant outcomes in select cases of intraductal papillary mucinous neoplasm with negative cytology

scientific article published on 20 August 2018

Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.

scientific article published on 23 May 2012

Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer

scientific article

Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer.

scientific article published on 31 August 2007

Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer

scientific article published in October 2008

Efficacy of dimethylaminoparthenolide and sulindac in combination with gemcitabine in a genetically engineered mouse model of pancreatic cancer

scientific article published on 01 January 2013

Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma

scientific article published on 13 December 2008

Factors influencing the cytotoxicity of α-methylene-γ-hydroxy esters against pancreatic cancer

scientific article published on 30 July 2015

Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts

scientific article published on 19 April 2017

Inhibition of the phosphatidylinositol 3'-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac

scientific article published in March 2003

Insurance Type and Marital Status Impact Hospital Length of Stay After Pancreatoduodenectomy

scientific article published on 11 September 2020

Intraductal Papillary Mucinous Neoplasia Originating From the Accessory (Santorini) Duct: A Rare Entity

scientific article published on 19 December 2020

Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection

scientific article published on 10 December 2020

MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac

scientific article published on November 2003

Multifocal High-Grade Pancreatic Precursor Lesions: A Case Series and Management Recommendations

scientific article published on 29 April 2019

Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma

scientific article published on March 2004

Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions

scientific article published on 07 October 2020

Natural and synthetic α,β-unsaturated carbonyls for NF-κB inhibition.

scientific article published on April 2009

Novel expression of vascular endothelial growth factor isoforms in the pancreas and pancreatic cystic lesions

scientific article published on 30 December 2020

PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia

scientific article published on 20 November 2007

Pancreatic Cyst Fluid Vascular Endothelial Growth Factor A and Carcinoembryonic Antigen: A Highly Accurate Test for the Diagnosis of Serous Cystic Neoplasm

scientific article published in 2017

Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia

scientific article published on 01 September 2019

Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies

scientific article

Pancreatic cyst fluid glucose: rapid, inexpensive, and accurate diagnosis of mucinous pancreatic cysts.

scientific article

Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.

scientific article

Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.

scientific article

Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest

scientific article published on June 2006

Performance of candidate urinary biomarkers for pancreatic cancer - Correlation with pancreatic cyst malignant progression?

scientific article published on 17 September 2019

Preoperative Nomogram Predicts Non-home Discharge in Patients Undergoing Pancreatoduodenectomy

scientific article published on 24 June 2020

Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes

scientific article published on 10 December 2018

Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia

scientific article published on 21 July 2017

Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association.

scientific article

Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells

scientific article

Response to Comment on Sims et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258-264

scientific article published on 01 May 2019

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

scientific article published on October 2006

Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.

scientific article

Secretin-induced Duodenal Aspirate of Pancreatic Juice (SIDA): Utility of Commercial Genetic Analysis

scientific article published on 01 August 2020

Sulindac prevents carcinogen-induced intrahepatic cholangiocarcinoma formation in vivo.

scientific article published on 7 November 2008

Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo.

scientific article published on 31 May 2007

Synthetic α-(aminomethyl)-γ-butyrolactones and their anti-pancreatic cancer activities.

scientific article published on 30 September 2013

Tailored α-methylene-γ-butyrolactones and their effects on growth suppression in pancreatic carcinoma cells

scientific article published on 21 September 2010

Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.

scientific article published on 21 July 2015

Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice

scientific article published on 7 November 2007

Targeting mitogen-activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems

scientific article published in April 2010

The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.

scientific article

The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.

scientific article

The first synthesis of a borylated α-methylene-γ-butyrolactone

scientific article published on April 2013

The proteome of normal pancreatic juice

scientific article published on March 2012

The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.

scientific article published on April 2008

Transforming growth factor α levels in pancreatic fluid

scientific article

Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts

scientific article published on 24 December 2013

Vascular endothelial growth factor: in reply to Giorgakis and colleagues

scientific article published on 01 September 2014